Cardlytics Inc expected to post a loss of 18 cents a share - Earnings Preview
26/02/2025 13:47
Cardlytics Inc CDLX.OQ CDLX.O is expected to show a fall in quarterly revenue when it reports results on February 28 (estimated) for the period ending December 31 2024 The Atlanta Georgia-based company is expected to report a 28.6% decrease in revenue to $63.627 million from $89.17 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on November 6 2024, for the period ended December 31, was for revenue between $62.00 million and $67.00 million. (SAL basis is Total Revenue) LSEG's mean analyst estimate for Cardlytics Inc is for a loss of 18 cents per share. The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Cardlytics Inc is $4.00, above its last closing price of $2.75. The company's guidance on November 6 2024 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 62 million and -1 million (USD). Previous quarterly performance (using preferred earnings measure in US dollars).
| QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
| Sep. 30 2024 | -0.25 | -0.24 | -0.15 | Beat | 38 |
| Jun. 30 2024 | -0.11 | -0.13 | -0.15 | Missed | -19 |
| Mar. 31 2024 | -0.10 | -0.11 | -0.09 | Beat | 18.2 |
| Dec. 31 2023 | 0.15 | 0.12 | 0.14 | Beat | 16.7 |
| Sep. 30 2023 | -0.01 | -0.01 | 0.01 | Beat | 200 |
| Jun. 30 2023 | -0.35 | -0.35 | -0.24 | Beat | 32.1 |
| Mar. 31 2023 | -0.56 | -0.56 | -0.25 | Beat | 55.7 |
| Dec. 31 2022 | -0.46 | -0.46 | -0.29 | Beat | 37.5 |
Recent news on Cardlytics
See all newsCardlytics Inc reports results for the quarter ended June 30 - Earnings Summary
Cardlytics Q2 revenue slightly misses estimates as billings fall
Cardlytics Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cardlytics Appoints Chris Cheng As Chief Legal Officer